Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort Study.

•Taking into account the internationally recommended statistical methodology, we constructed and internally validated a nomogram to predict recurrence probability in LSCC patients.•A risk prediction nomogram for patients with LSCC, incorporating readily assessable clinicopathologic variables, generates more accurate estimations of the recurrence probability when compared TNM stage alone.•Remarkably, DCA results showed that LSCC recurrence-related treatment decision based on the nomogram led to more net benefit than treatment decision based on TNM stage.